Babetta L. Marrone

High-speed DNA sequencing: An approach based upon fluorescence detection of single molecules

We are developing a laser based technique for the rapid sequencing of large fragments (approximately 40 kb) of DNA based upon the detection of single, fluorescently tagged nucleotides cleaved from a single DNA fragment. We have demonstrated significant progress on several of the important steps of this technique. The projected rate of sequencing is several hundred bases per second which is orders of magnitude faster than existing methods. Once developed, this technology could be utilized by investigators for rapid sequencing of genetic material from virtually any source.

Rapid DNA fingerprinting of pathogens by flow cytometry

BACKGROUND A new method for rapid discrimination among bacterial strains based on DNA fragment sizing by flow cytometry is presented. This revolutionary approach combines the reproducibility and reliability of restriction fragment length polymorphism (RFLP) analysis with the speed and sensitivity of flow cytometry. METHODS Bacterial genomic DNA was isolated and digested with a rare-cutting restriction endonuclease. The resulting fragments were stained stoichiometrically with PicoGreen dye and introduced into an ultrasensitive flow cytometer. A histogram of burst sizes from the restriction fragments (linearly related to fragment length in base pairs) resulted in a DNA fingerprint that was used to distinguish among different bacterial strains. RESULTS Five different strains of gram-negative Escherichia coli and six different strains of gram-positive Staphylococcus aureus were distinguished by analyzing their restriction fragments with DNA fragment sizing by flow cytometry. Fragment distribution analyses of extracted DNA were approximately 100 times faster and approximately 200,000 times more sensitive than pulsed-field gel electrophoresis (PFGE). When sample preparation time is included, the total DNA fragment analysis time was approximately 8 h by flow cytometry and approximately 24 h by PFGE. CONCLUSIONS DNA fragment sizing by flow cytometry is a fast and reliable technique that can be applied to the discrimination among species and strains of human pathogens. Unlike some polymerase chain reaction (PCR)-based methods, sequence information about the bacterial strains is not required, allowing the detection of unknown, newly emerged, or unanticipated strains.

Rapid DNA sequencing based upon single molecule detection

We are developing a laser-based technique for the rapid sequencing of 40-kb or larger fragments of DNA at a rate of 100 to 1000 bases per second. The approach relies on fluorescent labeling of the bases in a single fragment of DNA, attachment of this labeled DNA fragment to a support, movement of the supported DNA fragment into a flowing sample stream, and detection of individual fluorescently labeled bases as they are cleaved from the DNA fragment by an exonuclease. The ability to sequence large fragments of DNA will significantly reduce the amount of subcloning and the number of overlapping sequences required to assemble megabase segments of sequence information.

Separation of Escherichia coli bacteria from peripheral blood mononuclear cells using standing surface acoustic waves.

A microfluidic device was developed to separate heterogeneous particle or cell mixtures in a continuous flow using acoustophoresis. In this device, two identical surface acoustic waves (SAWs) generated by interdigital transducers (IDTs) propagated toward a microchannel, which accordingly built up a standing surface acoustic wave (SSAW) field across the channel. A numerical model, coupling a piezoelectric effect in the solid substrate and acoustic pressure in the fluid, was developed to provide a better understanding of SSAW-based particle manipulation. It was found that the pressure nodes across the channel were individual planes perpendicular to the solid substrate. In the separation experiments, two side sheath flows hydrodynamically focused the injected particle or cell mixtures into a very narrow stream along the centerline. Particles flowing through the SSAW field experienced an acoustic radiation force that highly depends on the particle properties. As a result, dissimilar particles or cells were laterally attracted toward the pressure nodes at different magnitudes, and were eventually switched to different outlets. Two types of fluorescent microspheres with different sizes were successfully separated using the developed device. In addition, Escherichia coli bacteria premixed in peripheral blood mononuclear cells (PBMCs) were also efficiently isolated using the SSAW-base separation technique. Flow cytometric analysis on the collected samples found that the purity of separated E. coli bacteria was 95.65%.

Beryllium sensitivity is linked to HLA-DP genotype.

Chronic beryllium disease (CBD) appears to arise from a combination of both exposure and genetic risk factors. A distinguishing feature of CBD is beryllium hypersensitivity, which can be measured in vitro by a lymphocyte proliferation test. The objective of this study was to determine whether certain allelic variations of the HLA-DPB1 gene, which had been observed previously in CBD, could be found in a group of individuals having beryllium hypersensitivity, but no symptoms of CBD. A flow cytometry-based Lymphocyte Proliferation Test combined with immunophenotyping (Immuno-LPT) was used to detect CD4+ and CD8+ T cell proliferation in response to in vitro stimulation with beryllium. The HLA-DPB1 haplotypes of the same individuals were determined by automated DNA sequencing. Twenty-two out of 25 beryllium-sensitive, non-CBD individuals were found to be carriers of the HLA-DPB1 gene having a substitution of a glutamic acid at position 69 in Exon 2 (Glu69), and a significantly high percentage (24%) were Glu69 homozygotes. Most of the CD4+ responders on the Immuno-LPT (10/14) carried rare, non-*0201 Glu69 DPB1 alleles; while most of the non-CD4+ responders (9/11) were common Glu69 carriers (*0201 or *0202) or non-Glu69 individuals (non-Glu69/non-Glu69). This is the first direct evidence that HLA-DP genotype is linked to a phenotypic response that occurs in beryllium sensitization in the absence of clinical CBD.

Quality Sample Collection, Handling, and Preservation for an Effective Microbial Forensics Program.

Science can be part of an effective investigative response to a bioterrorism event or a biocrime by providing capabilities to analyze biological and associated signatures in collected evidence. Microbial forensics, a discipline comprised of several scientific fields, is dedicated to the analysis of evidence from such criminal acts to help determine the responsible party and to exonerate the innocent (6). A partnership among a number of government agencies, academia, and the private sector has been formed to better respond to and deter potential perpetrators of bioterrorism or biocrimes. This partnership leverages our national scientific and analytical capabilities to support activities of law enforcement agencies. The Department of Homeland Security (DHS), whose mission is, in part, to respond to and to prevent acts of terrorism against the United States, has established the National Bioforensics Analysis Center (NBFAC) (4, 6). The NBFAC, in partnership with the Federal Bureau of Investigation (FBI), (i) provides a state-of-the-art central laboratory for analysis of microbial forensic evidence and (ii) serves as a nexus for integrating the national resources to increase the effectiveness of law enforcement in obtaining the highest level of attribution possible in criminal cases where the weapon is a biological agent. One approach used by the NBFAC to establish a sound foundation, to foster communication, and to facilitate integration across government and other agencies is to promote independent meetings, which address specific needs and provide a forum for input from the broader scientific community, on the best scientific practices in microbial forensics (5). As part of this ongoing effort, a series of meetings sponsored by DHS were held at the Banbury Center of the Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, to address specific issues for the enhancement of microbial forensic capability. One such meeting, held on 16 to 19 October 2005, focused on the collection, handling, and storage of samples. These issues had been identified at previous meetings (5, 6) as some of the most critical issues confronting a crime scene investigation and subsequent analysis of evidence. The participants represented diverse scientific entities within academia, the private sector, the national laboratories, and several federal agencies (Central Intelligence Agency, Centers for Disease Control and Prevention, DHS, FBI, Food and Drug Administration, and U.S. Department of Agriculture), some of which have been involved in evidence collection for purposes related to forensics, public health, or plant and animal health. The collection and preservation of microbial forensic evidence are paramount to efficient and successful investigation and attribution. If evidence (when available) is not collected, degrades, or is contaminated during collection, handling, transport, or storage, the downstream characterization and attribution analyses may be compromised. Retrieving sufficient quantities and maintaining the integrity of the evidence increase the chances of being able to characterize the material to obtain the highest level of attribution possible. This paper presents issues related to the practices of sample collection, handling, transportation, and storage and includes recommendations for future directions for the field of microbial forensics and people participating in it. The recommendations apply to the NBFAC, as well as to other facilities and practitioners.

Criteria for Validation of Methods in Microbial Forensics

A process for validation is essential in the development of methods that microbial forensics uses to generate reliable and defensible results. Law enforcement investigators need to respond quickly to the best leads to counter ever-increasing threats and will rely upon results generated from the analyses of any microbial forensic evidence to attempt to attribute any attack to a person(s) or group. Readily available technology and knowledge are making it easier for an individual or group to carry out biocrimes or bioterrorism using microorganisms and toxins as weapons. The potential that a biological weapon will be used is of serious concern for the safety and security of people and critical infrastructure. If a biocrime is committed, microbial forensic evidence will be sought, collected, and characterized to help investigators identify the perpetrator(s) and exclude innocent suspects. Analyses of collected material are often challenging because the identification of the signatures most useful for attribution often requires substantial effort (3). In addition, some microbial forensic specimens can be limited in quantity and/or quality. Despite these demands, accurate and credible results are needed because the interpretation of such results might seriously impact the course or focus of an investigation, thus affecting the liberties of individuals, or even be used as a justification for a government’s military response to an attack. Therefore, the methods for the collection, extraction, and analysis of microbial evidence that could generate key results need to be as scientifically robust as possible so that they are defensible to the legal community (12, 21) and, perhaps, to the international government, law enforcement, and scientific communities. Proper interpretation of the results of microbial forensic analysis relies substantially on understanding the performance and limitations of the methods of collection and the analytical processes, assays, and interpretation involved. Failing to properly validate a method or misinterpreting the results from a microbial forensic analysis or process may have severe consequences. DEFINING VALIDATION Validation is frequently used to connote confidence in a test or process. However, frequently, the process of validation is not well defined or properly described in context. Not being explicit about what is meant by validation can result in misinterpretation and misapplication of a properly performed test. It also can lead to a false sense of confidence in a poor method. In the nascent field of microbial forensics (5), there is a need to better describe what constitutes validation. A strict delineation of the steps needed to validate a method or process may be too restrictive; there are a myriad of methods, processes, targets, platforms, and applications. Yet some basic requirements transcend individual differences in methods, and these can be reinforced by contextual description and illustrated with examples. Failing to validate a method or misinterpreting the reliability of a method in a microbial forensic analysis can have dire consequences. This paper provides a framework for developing a validation plan that can be useful for microbial forensics and may have application to other scientific fields where “validation” may be used colloquially.

Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study.

In an effort to understand the molecular basis of chronic beryllium disease (CBD), a study of the chemical relationship between beryllium, antigen, and the major histocompatibility complex II, HLA-DP, was undertaken. A homology model of the HLA-DP protein was developed. An analysis of the sequences of HLA-DPB1 and HLA-DPA1 alleles most common among CBD patients revealed several carboxylate rich regions in the peptide-binding cleft. These regions contain many hard Lewis base sites that may provide bonding opportunities for beryllium, a hard Lewis acid. Quantum chemistry calculations and structural database results support the presence of beryllium clusters, bridged by carboxylate, hydroxo, and/or oxo ligands, in the HLA-DP binding cleft. These results strongly suggest that beryllium clusters are an integral part of the antigen, and may even act solely as antigen. This work provides an initial model for thinking about beryllium interactions with proteins relevant to CBD and other metal-induced diseases.

Inhibition of normal human lung fibroblast growth by beryllium

Inhalation of particulate beryllium (Be) and its compounds causes chronic Be disease (CBD) in a relatively small subset ( approximately 1-6%) of exposed individuals. Hallmarks of this pulmonary disease include increases in several cell types, including lung fibroblasts, that contribute to the fibrotic component of the disorder. In this regard, enhancements in cell proliferation appear to play a fundamental role in CBD development and progression. Paradoxically, however, some existing evidence suggests that Be actually has antiproliferative effects. In order to gain further information about the effects of Be on cell growth, we: (1) assessed cell proliferation and cell cycle effects of low concentrations of Be in normal human diploid fibroblasts, and (2) investigated the molecular pathway(s) by which the cell cycle disturbing effects of Be may be mediated. Treatment of human lung and skin fibroblasts with Be added in the soluble form of BeSO(4) (0.1-100 microM) caused inhibitions of their growth in culture in a concentration-dependent manner. Such growth inhibition was found to persist, even after cells were further cultured in Be(2+)-free medium. Flow cytometric analyses of cellular DNA labeled with the DNA-binding fluorochrome DAPI revealed that Be causes a G(0)-G(1)/pre-S phase arrest. Western blot analyses indicated that the Be-induced G(0)-G(1)/pre-S phase arrest involves elevations in TP53 (p53) and the cyclin-dependent kinase inhibitor CDKN1A (p21(Waf-1,Cip1)). That Be at low concentrations inhibits the growth of normal human fibroblasts suggests the possibility of the existence of abnormal cell cycle inhibitory responses to Be in individuals who are sensitive to the metal and ultimately develop CBD.

Immunophenotyping of chicken peripheral blood lymphocyte subpopulations: Individual variability and repeatability

T-cell lymphocyte populations can be delineated into subsets based on expression of cell surface proteins that can be measured in peripheral blood by monoclonal antibodies and flow cytometry percentages of the lymphocyte subpopulations. In order to accurately assess immunocompetence in birds, natural variability in both avian immune function and the methodology must be understood. Our objectives were to (1) further develop flow cytometry for estimating subpopulations of lymphocytes in peripheral blood from poultry, (2) estimate repeatability and variability in the methodology with respect to poultry in a free-range and environmentally diverse situation, and (3) estimate the best antibody and cell marker combination for estimating lymphocyte subpopulations. This work demonstrated the repeatability of using flow cytometry for measurements of peripheral blood in chickens using anti-chicken antibodies for lymphocyte subpopulations. Immunofluorescence staining of cells isolated from peripheral blood revealed that the CD3(+) antibodies reacted with an average of approximately 12-24% of the lymphoid cells in the blood, depending on the fluorescence type. The CD4(+) and CD8(+) molecules were expressed in a range of 4-31% and 1-10% of the lymphoid cells in the blood, respectively. Both fluorescence label and antibody company contribute to the variability of results and should be considered in future flow cytometry studies in poultry.